Research Article
Heat Shock Protein 27 Levels Predict Myocardial Inhomogeneities in Hemodialysis Patients
Table 1
Basic demographic data and clinical and biochemical data of patients.
| | Parameter | All patients
| Abnormal QRS-T
| Normal QRS-T
| |
| | Age (years) | | | | 0.011 | | HD vintage (months) | | | | 0.406 | | MI (%) | 31.9 | 44.4 | 26.6 | <0.001 | | Diabetes mellitus (%) | 52.2 | 61.1 | 48.4 | 0.001 | | Hypertension (%) | 81.8 | 83.3 | 81.2 | 0.213 | | Smoking | 19.2 | 18.5 | 19.5 | 0.273 | | Beta-blockers (%) | 85.7 | 87.0 | 85.1 | 0.304 | | ACE/ARB (%) | 75.8 | 74.1 | 75.8 | 0.625 | | Statins (%) | 61.5 | 64.8 | 60.23 | 0.236 | | LVMI (g/m2) | | | | <0.001 | | LVEF (%) | | | | <0.001 | | Hemoglobin (g/dL) | | | | 0.108 | | Total cholesterol (mg/dL) | | | | 0.312 | | LDL cholesterol (mg/dL) | | | | 0.411 | | HDL cholesterol (mg/dL) | | | | 0.699 | | Triglycerides (mg/dL) | | | | 0.328 | | PTH, range (pg/mL) | 380 (0.0-1212) | 351 (0.0-899) | 440 (0.0-1212) | 0.242 | | Albumin (g/dL) | | | | 0.731 | | CRP, range (mg/dL) | 7.34 (0.19-112.1) | 10.31 (0.019-112.1) | 6.89 (0.28-59.8) | 0.021 | | Troponin T, range (μg/L) | 0.057 (0.00-0.773) | 0.082 (0.00-0.773) | 0.039 (0.029-0.742) | 0.069 | | NT-proBNP (fmol/mL) | | | | 0.213 | | Sodium (mmol/L) | | | | 0.434 | | Potassium (mmol/L) | | | | 0.796 | | Calcium (mmol/L) | | | | 0.682 | | Phosphate (mmol/L) | | | | 0.267 | | Ca x P product (mg2/dl2) | | | | 0.245 | | TAC (μmol/L) | | | | 0.018 |
|
|
CAD: coronary artery disease; MI: history of myocardial infarction; ACE/ARB: angiotensin-converting enzyme inhibitors/angiotensin receptor blockers; LVMI: left ventricular mass index; LVH: left ventricular hypertrophy; LVEF: left ventricle ejection fraction; PTH: parathormone; CRP: C-reactive protein; NT-proBNP: N-terminal prohormone brain natriuretic peptide; TAC: total antioxidant capacity; TOC: total oxidant capacity; oxLDL: oxidized LDL; HSP27: heat shock protein 27.
|
